国医大师李佃贵基于“浊毒”理论辨治慢性萎缩性胃炎癌前病变胃黏膜屏障功能障碍  

National Master of TCM Li Diangui´s Experience in Differentiating and Treating Gastric Mucosal Barrier of Precancerous Lesions in Chronic Atrophic Gastritis Based on"Turbidity-toxin"Theory

作　　者：张慧[1,2] 姜璐 陈俊生[1] 张云松 李佃贵(指导)[1,2,3,4] ZHANG Hui;JIANG Lu;CHEN Junsheng;ZHANG Yunsong;LI Diangui(Shandong University of Traditional Chinese Medicine,Jinan 250014,China;Jinan Hospital of Traditional Chinese Medicine,Jinan 250014,China;Affiliated Hospital to Shandong University of Traditional Chinese Medicine,Jinan 250014,China;Hebei Provincial TCM Hospital,Shijiazhuang 050011,China)

机构地区：[1]山东中医药大学,山东济南250014 [2]济南市中医医院,山东济南250014 [3]山东中医药大学附属医院,山东济南250014 [4]河北省中医院,河北石家庄050011

出　　处：《西部中医药》2024年第8期47-50,共4页Western Journal of Traditional Chinese Medicine

基　　金：国家中医药管理局第六批全国老中医药专家学术经验继承项目(2018—2019);山东省中医药管理局齐鲁医派中医药特色技术推广项目。

摘　　要：国医大师李佃贵以“浊毒”理论为指导,基于本病脾虚毒损胃络的病机特点,分别采用化浊解毒、补虚荣络、祛瘀通络的治法以改善或增强胃黏膜屏障功能,降低慢性萎缩性胃炎癌变率。Under the guidance of"turbidity toxin"theory,based on the pathogenesis of spleen deficiency and toxin damaged stomach collateral,national master of TCM Li Diangui adopted resolving turbidity and detoxifying,tonifying the deficiency and nourishing the collateral,removing stasis and dredging the collateral respectively to improve or enhance gastric mucosal barrier function and reduce the rate of carcinogenesis of chronic atrophic gastritis(CAG).

关 键 词：萎缩性胃炎 浊毒 癌前病变 胃黏膜屏障 

分 类 号：R221[医药卫生—中医基础理论]